Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited

It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2001-2002. During the financial year, The Company’s Sales increased by 58% to Rs. 15,578 million, or US$ 319 million. EBITDA doubled to Rs. 5,314 million, or US$ 109 million and EBITDA margin increased from 26% in 2000-01 to 34% in 2001-02. Profit after tax (PAT) more than trebled to Rs. 4,597 million, or US$ 94 million. And, earnings per share (EPS) grew from Rs. 22.83 in 2000-01 to Rs. 60.41 in 2001-02.

The Board of Directors is pleased to recommend a dividend of Rs. 2.50 per equity share of Rs. 5/- for the financial year 2001-2002. This dividend along with the interim dividend of 100%, which has already been paid, raises the total dividend for the financial year 2001-2002 to 150%.

More Annual Report of Dr. Reddy’s Laboratories Limited:

  1. Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
  2. Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
  3. Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
  4. Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
  5. Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
  6. Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
  7. Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
  8. Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
  9. Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
  10. Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
  11. Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
  12. Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
  13. Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
  14. Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
  15. Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
  16. Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited